| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0009 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0009 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |